Clinical Trial: Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06857565) titled 'Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections' on Feb. 22.

Brief Summary: This randomized, open-label, controlled clinical trial evaluates the efficacy and safety of Lactobacillus crispatus M247 (CRISPACT(R)) in preventing recurrent urinary tract infections (rUTIs) in women. The study will enroll 130 adult female participants with a history of recurrent UTIs, defined as >=3 episodes in the past year or >=2 episodes in the past six months. Participants will be randomized into two groups: the Probiotic Group, receiving iNatal-duo(R) (containing Bifi...